NCT07631468
PROspect Registry :Post Market Clinical Follow-up Study
Not Yet Recruiting
Not specifiedAges 18+ObservationalStryker Endoscopy
~5,000 participants
Updated 2026-06-08 on ClinicalTrials.gov
What's tested:Standard of care treatment
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Successful marker localization
Measured over From the start of surgery to completion of surgery for each participant (assessed intraoperatively, up to the duration of the surgical procedure, typically within the same day)
+1 more outcome measured
Conditions
Where it's being run
1 sites across 1 statesMassachusetts1
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Subject was ≥ 18 years of age at the time of the surgery
Patients who have undergone breast surgical procedures using MOLLI, SPY-PHI, and/or SPY AGENT GREEN
Exclusion
Subjects who are less than 1-month post-intervention
Concurrent participation in an interventional investigational clinical study at the time of initial surgery
Subjects whose surgery date was prior to January 2022.
Pregnant or lactating females at the time of initial surgery
What this trial measures
- Successful marker localizationFrom the start of surgery to completion of surgery for each participant (assessed intraoperatively, up to the duration of the surgical procedure, typically within the same day)
(proportion of MOLLI markers that are detected intraoperatively)
- Marker retrieval successFrom the start of surgery to completion of surgery for each participant (assessed intraoperatively, up to the duration of the surgical procedure, typically within the same day)
(proportion of procedures in which the MOLLI marker is removed within the surgical specimen)